Prof Michael Henderson
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
48 Scholarly works
2 Projects
HIGHLIGHTS
2025
Journal article
Applying Radiomics to Predict Outcomes in Patients with High-Grade Retroperitoneal Sarcoma Treated with Preoperative Radiotherapy
DOI: 10.3390/jimaging111204502024
Book Chapter
Mucosal melanoma
DOI: 10.1201/9781315140711-182023
Journal article
Regarding: Predicting Regional Lymph Node Recurrence in The Modern Age of Tumor-Positive Sentinel Node Melanoma
DOI: 10.1245/s10434-023-13570-92022
Journal article
Factors influencing acceptance, adoption and adherence to sentinel node biopsy recommendations in the Australian Melanoma Management Guidelines: a qualitative study using an implementation science framework
DOI: 10.1186/s43058-022-00351-w2022
Journal article
A Phase III, Multicenter, Randomized Controlled Trial Investigating 1-cm Versus 2-cm Surgical Excision Margins for Stage II Primary Cutaneous Melanoma (MelMarT-II)
DOI: 10.1245/s10434-022-11766-z2022
Journal article
Impact of chronic lymphocytic leukaemia on melanoma outcomes: A retrospective case-control study
DOI: 10.1111/bjh.180902022
Journal article
Cutaneous squamous cell carcinoma metastatic to the axilla and groin: Outcomes and prognostic factors
DOI: 10.1111/ajd.13739
RECENT SCHOLARLY WORKS
2022
Journal article
BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting
DOI: 10.1016/j.pathol.2021.11.0022021
Journal article
Characterising the immune microenvironment in liposarcoma, its impact on prognosis and the impact of radiotherapy
DOI: 10.1002/jso.262612020
Journal article
Surgical management of recurrent cutaneous squamous cell carcinoma of the head and neck after definitive surgery and radiotherapy
DOI: 10.1111/ans.16095
RECENT PROJECTS
Research Grant
Detection of Occult Disseminating Tumour Cells and Tumour Dna in Early Stage Operable Breast Cancer Patients
Research Grant
A Trial of Surgery Versus Surgery Plus Adjuvant Radiotherapy in Patients With Resected Nodal Metastatic Melanoma